Med-X Company Updates

In this video, COO and President, Matthew Mills updates everyone on the launch of the new shareholder dashboard. The initial launch on Oct. 21st was a success with over 1,100 shareholders successfully verifying and gaining access to their dashboard.

In this video update President and COO, Matthew Mills announces the engagement with Global Capital Group, Year-to-date Revenue Numbers, and how to access the new Med-X Shareholder Dashboard. This update is full of important information so please take the time to read the entire update. Global private financial group, US Capital Global, headquartered in San Francisco engaged by Med-X, Inc., Los Angeles-based green technology manufacturer as a strategic advisor.

In this important update, COO and President, Matthew Mills discusses a strategic plan to list the Company on a national exchange to support and bolster the growth of the Nature-Cide and the Thermal-Aid divisions. Matthew Mills also reports on exciting news regarding the Company’s revenue growth, progress with institutional investment firms and the status of the Nature-Cide toxicity testing. Please watch this important announcement. With the recipe of essential products and services, growing revenue, international distribution positioning, all while negotiating with a handful of investment banking firms, the management team has decided to move forward with the plan to execute an Initial Public Offering.

In this video update, COO, Matthew Mills, updates the company shareholders on the continued growth of the Nature-Cide Professional products as well as additional growth on Amazon from our Nature-Cide Ready to Use products. Matthew also announces the launch of an additional capital raising campaign, a Regulation CF Offering, that will offer new potential investors on the TruCrowd platform the opportunity to get involved. In addition, Matthew also discusses the recently filed 1-K Annual Report, progress with toxicity testing and the on-going efforts to bring on institutional investors to advance the company more rapidly. The Full Regulation CF Press Release can be seen at the end of this update.

To our Shareholders, In response to the COVID-19 pandemic, we want to share that our focus is on continuing to keep our shareholders informed. In that regard, the Securities and Exchange Commission (“SEC”) earlier this month announced that due to the impact of COVID-19 on businesses, it was providing Regulation A+ companies a 45-day extension to file its Form 1-K Annual Report. Because Med-X personnel and audit personnel are now working remotely as much as possible and relying on our staff to scan and email work papers and other documents, the Company’s ability to complete its audit and file the 2019 Form 1-K prior to its due date is delayed. Notwithstanding the foregoing, the Company expects to file the 2019 Form 1-K shortly but no later than June 13, 2020 (which is 45 days from the 2019 Form 1-K’s original filing deadline of April 29, 2020).

In this update video, President and COO, Matthew Mills, discusses how the company has managed to keep generating revenue during the current California and Los Angeles County Stay-at-Home order, by continuing to fulfill essential business demands. Nature-Cide and Thermal-Aid continue to see a steady amount of orders going out to our multiple distribution partners, as well as facilitating consumers directly via our Amazon FBA positions.

In this update COO, Matthew Mills informs the company shareholders that the company has taken the necessary steps and guidance to protect the team members who are working to fulfill orders that continue to come in. Our entire team is safe and we are prepared to do whatever is necessary to protect the company's assets and support the needs of our customers and the community. Seemingly our products continue to carry a popular position, even in difficult times.

In this update, President & COO, Matthew Mills announces the Company has reached its first crowdfunding capital raising milestone of $1,000,000. He also gives us an update on the acquisition front as well as an important request. The $1,000,000 milestone on any crowdfunding offering is always something to celebrate!! 🙏🎉🎊🎈 We are grateful for all of the shareholders who have participated in the Med-X offerings and excited to see what 2020 has brought so far. We certainly couldn't be seeing brand growth along with green philosophy approaches, that our professional use and consumer customers are practicing daily, without our amazing shareholder’s support!

It has been a very busy month so far here in Los Angeles. We have a lot to cover and it is important that all shareholders receive this information. In this video update, Matthew brings us up to speed on developments to date in January 2020. Some of the topics Matthew touches on in the video are: Status of the Custom Bed Bug Acquisition. Announcement of Nature-Cide making the shortlist of approved pesticides for the cultivation of industrial hemp in the state of Kentucky. A statement that production begins on CBD Formulation of the Malibu Brands Pacific Pain Relief Cream. The introduction of Bugly, the first at-home retail membership for an all-natural “Do It Yourself” pest control program, that is a private label partnership with Nature-Cide. Journal of the Florida Mosquito Control Association published a study showing the results of a two-year comprehensive study testing the efficacy of 25(b) products alongside the top three global pyrethroid products. The results are astonishing. Status of the pesticide toxicology testing overview. Review of product retail positions and status update on the 2020 inventory needs for all retail brands. Statement regarding Glendale Securities' position with the Company in preparation for the next steps after the potential acquisition. Status of moving the Reg. A+ offering away from StartEngine onto our own independent platform and the launch of a new Regulation Crowdfunding Offering that will be run and overseen by the StartEngine Broker-Dealer Division and run on their platform.

2019 Year-End Review and Outlook for 2020 Happy New Year! As we close out the end of this amazing year I wanted to take some time and reflect back on a few important milestones the company was able to accomplish in 2019 and then cover some important items as we start 2020. It was a very productive year and we are set up nicely to have an even more productive year in 2020. A year in review: Nature-Cide products were introduced and sold to the professional turf grass industry for the first time. Nature-Cide’s international footprint grew with Rentokil in several new countries. Nature-Cide committed to a larger strategic marketing plan with the largest pest control distributors and industry publications. The company launched its Acquisition Company Roll-Up Strategy and entered into talks with several targets in the pest control service arena. The company signed a letter of intent and is working to close its first pest control service acquisition. The company reserved the Nasdaq Symbol “MXRX”. Malibu Brands Pacific Pain Relief Cream was launched. The company successfully closed its first Regulation A+ offering on StartEngine in June of 2019 capping the round off in the neighborhood of $7 million raised since 2016. The company signed with broker-dealer NMS Capital to partner on its new Regulation A+ capital raise. The company launched the National Investor Network. The Marijuana Times helped break the story on contaminated cannabis oil being sold on the black market. Thermal-Aid products saw growth from Cardinal Health Distribution and direct-to-consumers. Nature-Cide delivered hundreds of samples of products to professionals in 2019 as the word spread around the world. The company launched its own investment platform for its new Regulation A+ offering. The company surpassed its 2018 revenue in Q4 and reached its 2019 revenue goals. It was a challenging but satisfying year for our company. All of the support from our shareholders and partners allowed us to keep this movement going in a positive direction. The brands themselves, especially Nature-Cide, has become globally known as a premier Green Pest Control product line.